发明授权
US08026255B2 Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists
失效
取代的哌啶作为生长抑素受体5型（SSTR5）拮抗剂
- 专利标题： Substituted piperidines as somatostatin receptor subtype 5 (SSTR5) antagonists
- 专利标题（中）： 取代的哌啶作为生长抑素受体5型（SSTR5）拮抗剂
-
申请号： US12776748申请日： 2010-05-10
-
公开(公告)号： US08026255B2公开(公告)日： 2011-09-27
- 发明人: Alfred Binggeli , Andreas D. Christ , Hans P. Maerki , Rainer E. Martin
- 申请人： Alfred Binggeli , Andreas D. Christ , Hans P. Maerki , Rainer E. Martin
- 申请人地址： US NJ Nutley
- 专利权人： Hoffman-La Roche Inc.
- 当前专利权人： Hoffman-La Roche Inc.
- 当前专利权人地址： US NJ Nutley
- 代理商 George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- 优先权： EP06118923 20060815
- 主分类号： A61K31/445
- IPC分类号： A61K31/445
摘要：
This invention is concerned with compounds of the formula and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
公开/授权文献
信息查询
IPC分类:
